FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a method for producing a dry plant extract with antiviral activity against influenza A(H1N1) virus and antioxidant activity. A method for obtaining a dry plant extract with antiviral activity against the influenza A(H1N1) virus and antioxidant activity, including grinding the inflorescences of Sorbaria sorbifolia to a particle size of 20-30 mm, followed by extraction with 70% ethanol three times at a temperature of 60°C, in the ratio of raw materials:solvent 1:20 for the first extraction for 4 hours, 1:15 for the second extraction for 2 hours, 1:15 for the third extraction for 2 hours, pooling, cooling the combined obtained filtrates to room temperature, concentrating in household dehydrator and drying to a residual moisture content of 5%, followed by storage in the dark at room temperature and air humidity of 30-60%.
EFFECT: above method allows you to save the composition and amount of extractable substances and obtain an extract with a pronounced antiviral activity against the influenza A(H1N1) virus and antioxidant activity.
1 cl, 2 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL FLAVONOID COMPOUND | 2006 |
|
RU2398595C2 |
WATER-SOLUBLE PIGMENT MELANIN FROM THE BASIDIOMYCETE INONOTUS OBLIQUUS WITH ANTIVIRAL ACTIVITY | 2022 |
|
RU2800446C1 |
MELANINE ANTIVIRAL AGENT | 2011 |
|
RU2480227C2 |
ANTIVIRAL AGENT BASED ON DRY EXTRACT OF LICHEN Cetraria islandica | 2015 |
|
RU2580305C1 |
COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | 2009 |
|
RU2505306C2 |
ANTIVIRAL AGENT BASED ON TOTAL AMOUNT OF FLAVONOIDS FROM Alchemilla vulgaris L | 2015 |
|
RU2580304C1 |
NEW STANDARTISED COMPOSITION, METHOD FOR PREPARING AND USING IT IN RNA-VIRAL INFECTION REGRESSION | 2009 |
|
RU2472502C2 |
STRAIN OF ASIDIOMYCETE DAEDALEOPSIS CONFRAGOSA, CONTAINING PROTEINS, EXHIBITING ANTICANCER AND ANTIVIRAL ACTIVITY | 2017 |
|
RU2663111C1 |
SARS-COV-2 REPLICATION INHIBITOR BASED ON A WATER EXTRACT OF THE FUNGUS INONOTUS OBLIQUUS | 2020 |
|
RU2741714C1 |
METHOD FOR PRODUCING PROPHYLACTIC ANTIVIRAL COMPOSITION BASED ON EPIGALLOCATECHIN-3-GALLATE (EGCG) | 2021 |
|
RU2771898C1 |
Authors
Dates
2022-05-19—Published
2021-12-14—Filed